
baybiosciences.com
Nov 13, 2024, 23:26
Efficacy of subsequent therapies in advanced ovarian cancer
Annals of Oncology shared a post on X:
“New article in press: Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 04:13
Mar 30, 2025, 03:45
Mar 30, 2025, 03:26
Mar 30, 2025, 03:18
Mar 29, 2025, 23:14
Mar 29, 2025, 23:04